Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human B lymphocyte stimulator receptor antibody fusion protein plus methotrexate in rheumatoid arthritis
CTR20130580Phase 2Completed
- Sponsor
- RemeGen
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in rheumatoid arthritis (RA), sponsored by RemeGen. Started Apr 2014; status: completed.
02
Drugs
belimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20130580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130580.